scholarly journals A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma

2012 ◽  
Vol 31 (1) ◽  
pp. 99-107 ◽  
Author(s):  
Thomas Yau ◽  
P. N. Cheng ◽  
Pierre Chan ◽  
William Chan ◽  
Li Chen ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase 1 ◽  
Advanced Hepatocellular Carcinoma ◽  
Arginase 1 ◽  
Dose Escalating

Phase 1 study of N 1,N 11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma

2013 ◽  
Vol 72 (6) ◽  
pp. 1305-1314 ◽  
Author(s):  
Lipika Goyal ◽  
Jeffrey G. Supko ◽  
Jordan Berlin ◽  
Lawrence S. Blaszkowsky ◽  
Amanda Carpenter ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase 1 ◽  
Advanced Hepatocellular Carcinoma ◽  
Phase 1 Study

scholarly journals Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

The Lancet ◽  
2017 ◽  
Vol 389 (10088) ◽  
pp. 2492-2502 ◽  
Author(s):  
Anthony B El-Khoueiry ◽  
Bruno Sangro ◽  
Thomas Yau ◽  
Todd S Crocenzi ◽  
Masatoshi Kudo ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Dose Escalation ◽  
Phase 1 ◽  
Advanced Hepatocellular Carcinoma ◽  
Open Label

Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

2011 ◽  
Vol 30 (4) ◽  
pp. 1540-1547 ◽  
Author(s):  
Su Jin Lee ◽  
Jeeyun Lee ◽  
Se Hoon Park ◽  
Joon Oh Park ◽  
Young Suk Park ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase 1 ◽  
Advanced Hepatocellular Carcinoma ◽  
Phase 1 Trial
Sign in / Sign up

Export Citation Format

Share Document